News & Updates

Elevated sugar intake ups premature ageing risk in childhood cancer survivors

An elevated intake of sugar may increase the risk of premature ageing among childhood cancer survivors, according to a study presented at the recent AACR Special Conference: Aging and Cancer.

Daunorubicin for newly diagnosed AML: Does more equate to better outcomes?

In acute myeloid leukaemia (AML) patients who received the 7+3* induction, a higher daunorubicin dose or a double induction did not seem to yield better outcomes, findings from the two-part phase III SAL Dauno-Double trial suggest.

TACE + apatinib: A potential new strategy for intermediate/advanced HCC?

RT, SCC predict positive response to therapy in esophageal cancer

A favourable pathologic response (FPR) is associated with improved overall survival following neoadjuvant therapy in patients with esophageal and gastroesophageal cancer (GEJ), reveal the results of a recent study. Of note, squamous cell carcinoma and radiation therapy-based protocol are significant predictors of FPR in these patients.

Examined lymph node count linked to better survival in typical carcinoid tumours

In patients with early-stage typical carcinoid tumours (TC), long-term survival rate increases with higher examined lymph nodes (ELNs), suggests a study.

JAVELIN Bladder 100: Sustained survival benefit with avelumab + BSC in Asians with advanced UC

Longer-term follow-up results of the JAVELIN Bladder 100 trial continue to show prolonged overall survival (OS) and progression-free survival (PFS) with avelumab first-line maintenance and best supportive care (BSC) among Asian patients with advanced urothelial carcinoma (UC) compared with BSC alone.